Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Bionomics and Merck Serono terminate agreement

June 19, 2012

Ambrx and Merck & Co. to design optimized biologic-drug conjugates

June 19, 2012

KineMed enters collaboration with GSK

June 19, 2012

Debiopharm and Ascepion enter license agreement for multikinase inhibitor

June 18, 2012

MD Anderson Cancer Center joins phase I LOR-253 study

June 15, 2012

JDRF and Novo Nordisk establish type 1 diabetes partnership

June 14, 2012

ImaginAb and BZL Biologics expand collaboration

June 13, 2012

GE Healthcare to provide imaging agent to Australian government for Alzheimer's study

June 12, 2012

Stiefel acquires worldwide rights to Toctino

June 12, 2012

Astellas and DNDi launch drug discovery collaboration for three neglected tropical diseases

June 12, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.